CT and MR imaging of hepatic metastases

American Journal of Roentgenology

Volumn 174, Issue 3, 2000, Pages 691-698

  Sica, Gregory T ^a   Ji, Hoon ^a   Ros, Pablo R ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

EID: 0034001015     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.174.3.1740691     Document Type: Review

References (75)

1. Ackerman NB, Lien WM, Kondi ES, Silverman NA. The blood supply of experimental liver metastases. I. Distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 1969;66:1067-1072
2. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-337
3. Dodd GD, Baron RL. The investigation of contrast enhancement in CT of the liver: the need for improved methods. AJR 1993;160:643-646
4. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. AJR 1994; 163:323-331
5. Heiken JP, Brink JA, McClennan BL, Sagel S, Forman HP, Dicroce J. Dynamic contrast-enhanced CT of the liver: comparison of contrast medium injection rates and uniphasic and biphasic injection protocols. Radiology 1993;187:327-331
6. Bruneton JN, Falewee MN, Francois E, et al. Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide. Radiology 1989;170:179-183
7. Miller DL, Vermess M, Doppman JL, et al. CT of the liver and spleen with EOE-13: review of 225 examinations. AJR 1984;143:235-243
8. Laniado M, Kopp AF. Liver-specific contrast media: a magic bullet or a weapon for dedicated targets? Radiology 1997;205:319-322
9. Birnbaum BA, Jacobs JE, Dongping Y. Hepatic enhancement during helical CT: a comparison of moderate rate uniphasic and biphasic contrast injection protocols. AJR 1995;165:853-858
10. Garcia PA, Bonaldi VM, Bret PM, Liang L, Reinhold C, Atri M. Effect of rate of contrast medium injection on hepatic enhancement at CT. Radiology 1996;199:185-189
11. Silverman PM, Roberts S, Tefft MC, et al. Helical CT of the liver: clinical application of an automated computer technique, SmartPrep, for obtaining images with optimal contrast enhancement. AJR 1995; 165:73-78
12. Paulson EK, Fisher AJ, DeLong DM, Parker DD, Nelson RC. Helical liver CT with computer assisted bolus-tracking technology: is it possible to predict which patients will not achieve a threshold of enhancement? Radiology 1998;209:787-792
13. Kuszyk BS, Bluemke DA, Urban BA, et al. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings. AJR 1996;166:91-95
14. Bonaldi VM, Bret PM, Reinhold C, Atri M. Helical CT of the liver: value of an early hepatic arterial phase. Radiology 1995;197:357-363
15. Hollen MD, Jeffrey RB Jr, Nino-Murcia M, Jorgensen MJ, Harris DP. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (≤1.5 cm) malignant hepatic neoplasms. AJR 1995;164:879-884
16. Van Hoe L, Baert AL, Gryspeerdt S, et al. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions. AJR 1997;168:1185-1192
17. Miller FH, Butler RS, Hoff FL, Fitzgerald SW, Nemcek AA Jr, Gore RM. Using triphasic helical CT to detect focal hepatic lesions in patients with neoplasms. AJR 1998;171:643-649
18. Paulson EK, McDermott VG, Keogan MT, DeLong D, Frederick MG, Nelson RC. Carcinoid metastases to the liver: role of triple-phase helical CT. Radiology 1998;206:143-150
19. Van Leeuwen MS, Noordzij J, Feldberg MA, Hennipman AH, Doornewaard H. Focal liver lesions: characterization with triphasic spiral CT. Radiology 1996;201:327-336
20. Urban BA, Fishman EK, Kuhlman JE, Kawashima A, Hennessey JG, Siegelman SS. Detection of focal hepatic lesions with spiral CT: comparison of 4-and 8-mm interscan spacing. AJR 1993;160:783-785
21. Leslie DF, Johnson CD, MacCarty RL, Ward EM, Ilstrup DM, Harmsen WS. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. AJR 1995;165:1403-1406
22. Leslie DF, Johnson CD, Johnson CM, Ilstrup DM, Harmsen WS. Distinction between cavernous hemangiomas of the liver and hepatic metastases on CT: value of contrast enhancement patterns. AJR 1995;164:625-629
23. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H. Hepatic hemangioma: findings with two-phase CT. Radiology 1995;196:465-469
24. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994;192:401-406
25. Muramatsu Y, Takayasu K, Moriyama N, et al. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology 1986;160:49-52
26. Soyer P, Bluemke DA, Vissuzaine C, Van Beers B, Barge J, Levesque M. CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. AJR 1994;162:1119-1122
27. Apicella PL, Mirowitz SA, Weinreb JC. Extension of vessels through hepatic neoplasms: MR and CT findings. Radiology 1994;191:135-136
28. Soyer P, Bluemke DA, Fishman EK. CT during arterial portography for the preoperative evaluation of hepatic tumors: how, when, and why? AJR 1994;163:1325-1331
29. Heiken JP, Weyman PJ, Lee JK, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989;171:47-51
30. Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK. Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. Radiology 1994;193:71-74
31. Ward BA, Miller DL, Frank JA, et al. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery 1989;105:180-187
32. Bluemke DA, Soyer PA, Chan BW, Bliss DF, Calhoun PS, Fishman EK. Spiral CT during arterial portography: technique and applications. RadioGraphics 1995;15:623-637
33. Soyer P, Lacheheb D, Levesque M. False-positive CT portography: correlation with pathologic findings. AJR 1992;160:285-289
34. Chezmar JL, Bernardino ME, Kaufman SH, Nelson RC. Combined CT arterial portography and CT hepatic angiography for evaluation of the hepatic resection candidate. Radiology 1993;189:407-410
35. Nazarian LN, Wechsler RJ, Grady CK, et al. CT done 4-6 hr after CT arterial portography: value in detecting hepatic rumors and differentiating from other hepatic perfusion defects. AJR 1994;163:851-855
36. Runge VM, Tammo HP, Davidoff A, Wells JW, Stark DD. Contrast-enhanced MR imaging of the liver. J Magn Reson Imaging 1994;4:281-289
37. Grant D, Zech K, Holtz E. Biodistribution and in vivo stability of manganese dipyridoxyl diphosphate in relation to imaging efficacy. Invest Radiol 1994;29[suppl]:S249-S250
38. Gallez B, Bacic G, Swartz HM. Evidence for the dissociation of the hepatobiliary MRI contrast agent Mn-DPDP. Magn Reson Med 1996;35:14-19
39. Lim KO, Stark DD, Leese P, et al. Hepatobiliary MR imaging: first human experience with Mn-DPDP. Radiology 1992;178:79-82
40. Marchal G, Ni Y, Zhang X, Yu J, Lodemann KP, Baert AL. Mn-DPDP enhanced MRI in experimental bile duct obstruction. J Comput Assist Tomogr 1993;17:290-296
41. Ni Y, Petre C, Lukito G, et al. Effect of manganese dipyridoxal diphosphate on liver magnetic resonance imaging and serum bilirubin in rats with removable biliary obstruction. Acad Radiol 1995;2:300-305
42. Murakami T, Baron RL, Federle MP, et al. Cirrhosis of the liver: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996; 198:567-572
43. Van Beers BE, Gallez B, Pringot J. Contrast-enhanced MR imaging of the liver. Radiology 1997; 203:297-306
44. Petersein J, Saini S, Weissleder R. Liver. II: Iron oxide-based reticuloendothelial contrast agents for MR imaging. Magn Reson Imaging Clin N Am 1996;4:53-60
45. Bellin MF, Zaim S, Auberton E, et al. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. Radiology 1994;193:657-663
46. Kuwatsuru R, Brasch RC, Muhler A. et al. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. Radiology 1997;202:131-138
47. Semelka R, Bagley AS, Brown ED, Kroeker MA. Malignant lesions of the liver identified on T1-but not T2-weighted MR images at 1.5 T. J Magn Reson Imaging 1994;4:315-318
48. Saini S, Li W, Wallner B, Hahn PF, Edelman RR. MR imaging of liver metastases at 1.5 T: similar contrast discrimination with T1-and T2-weighted sequences. Radiology 1991;181:449-453
49. de Lange EE, Mugler JP III, Bosworth JE, et al. MR imaging of the liver: breath-hold T1-weighted MP-GRE compared with conventional T2-weighted SE imaging - lesion detection, localization, and characterization. Radiology 1994; 190:727-736
50. Soyer P, de Givry SC, Gueye C, Lenormand S, Somveille E, Scherrer A. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging. AJR 1996;166:1115-1121
51. Yamashita Y, Hatanaka Y, Yamamoto H, et al. Differential diagnosis of focal liver lesions: role of spin-echo and contrast-enhanced dynamic MR imaging. Radiology 1994;193:59-65
52. Hamm B, Mahfouz A, Taupitz M, et al. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging. Radiology 1997; 202:677-682
53. Peterson MS, Baron RL, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology 1996;201:337-345
54. Steinberg HV, Alarcon JJ, Bernardino ME. Focal hepatic lesions: comparative MR imaging at 0.5 and 1.5 T. Radiology 1990;174:153-156
55. Schwartz LH, Seltzer SE, Tempany CMC, et al. Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse sequences in the upper abdomen. Radiology 1993;189:411-416
56. Yamashita Y, Tang Y, Namimoto T, Mitsuzaki K, Takahashi M. MR imaging of the liver: comparison between single-shot echo-planar and half-Fourier rapid acquisition with relaxation enhancement. Radiology 1998;207:331-337
57. Tang Y, Yamashita Y, Mnamimoto T, Abe Y, Takahashi M. Liver T2-weighted MR imaging: comparison of fast and conventional half-Fourier single-shot turbo spin-echo, breath-hold spin-echo, and respiratory-triggered turbo spin-echo sequences. Radiology 1997;203:766-772
58. Murakami T, Baron R, Peterson MS, et al. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP). Radiology 1996;200:69-77
59. Giovagnoni A, Pad E, Liver, III. Gadolinium-based hepatobiliary contrast agent (Gd-EOB-DTPA and Gd-BOPTA/Dimeg): contrast agents for body MR imaging. Magn Reson Imaging Clin N Am 1996;4:61-72
60. Low RN. Contrast agents for MR imaging of the liver. J Magn Reson Imaging 1997;7:56-67
61. Vogl TJ, Hammerstingl R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. Radiology 1996; 198:881-887
62. Mergo PJ, Helmbeger T, Nicolas Al, Ros PR. Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. AJR 1996;166:379-384
63. Wittenberg J, Stark DD, Forman BH, et al. Differentiation of hepatic metastases from hepatic hemangiomas and cysts by using MR imaging. AJR 1988;151:79-84
64. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. MRI appearance of hepatic colorectal metastases with pathologic correlation. Radiology 1991;180:327-332
65. Kelekis NL, Semelka RC, Woosley JT. Malignant lesions of the liver with high signal intensity on T1-weighted images. J Magn Reson Imaging 1996;6:291-294
66. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal lesions. Radialogy 1994;190:49-52
67. Valls C, Lopez E, Gumà A, et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. AJR 1998;170:1341-1347
68. Semelka RC, Schlund JF, Molina PL, et al. Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging 1996;6:39-43
69. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: comparison of dynamic contrast-enhanced CT and T2-weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992; 184:687-694
70. Rummeny EJ, Weniecke K, Saini S, et al. Comparison between high-field strength MR imaging and CT for screening of hepatic metastases: a receiver operating characteristic analysis. Radiology 1992;182:879-886
71. Semelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, and effect on patient management: comparison of single -phase spiral CT and current MR techniques. J Magn Reson Imaging 1997;7:1040-1047
72. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996;200:785-792
73. Hamm B, Vogl TJ, Branding G, et al. Focal liver lesions: MR imaging with Mn-DPDP - initial clinical results in 40 patients. Radiology 1992;182:167-174
74. Padovani B, Lecesne R, Raffaelli C, Laurent FH, Drouillard J, Bruneton JN. Phase III study of Mn-DPDP in MR imaging and contrast-enhanced CT (abstr). Radiology 1995;197(P):415
75. Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 1996;200:59-67